BioSpace News Archive

Business

Hologic’s Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries

Program focuses on infectious disease assays - including HIV - for countries where critical testing is needed most

July 25, 2018
·
5 min read
Business

Concordia International Corp. Announces Release Date for Second Quarter 2018 Results

Company also provides anticipated timing update for closing of its Recapitalization Transaction

July 25, 2018
·
7 min read
Policy

Medicenna Strengthens Empowered Cytokine Platform with Notice of Allowance of US Patent

Medicenna Therapeutics Corp. announced that the United States Patent and Trademark Office issued a Notice of Allowance related to the Company’s MDNA57 program.

July 25, 2018
·
5 min read
Policy

Finch Therapeutics Expands Its Leading Microbiome IP Estate with Six New Patents

Finch Therapeutics Group, Inc. announced that the U.S. Patent and Trademark Office (USPTO) has issued six new patents to Finch covering its Full-Spectrum Microbiota (FSM) and Rationally-Selected Microbiota (RSM) product platforms.

July 25, 2018
·
3 min read
Business

Eagle Pharmaceuticals, Inc. to Discuss Second Quarter 2018 Financial Results on August 7, 2018

Eagle Pharmaceuticals, Inc. announced that the Company will release its 2018 second quarter financial results on Tuesday, August 7, 2018, before the market opens.

July 25, 2018
·
1 min read
Deals

Alector Announces $133 Million in Series E Financing to Advance Broad Portfolio of Immuno-Neurology and Immuno-Oncology Programs

First three programs to focus on Alzheimer’s disease and frontotemporal dementia

July 25, 2018
·
3 min read
Business

TherapeuticsMD to Report Second Quarter 2018 Financial Results on July 30, 2018

Executive Management to Host Conference Call on July 30, 2018 at 8:30 a.m. ET

July 25, 2018
·
4 min read
Biotech Bay

Data from BioTime’s OpRegen® Program to Be Presented at AAO 2018

Presentation to include data from new as well as previously treated patients

July 25, 2018
·
4 min read
BioMidwest

Probiotic with Digestive Enzymes Supplement Demonstrated to Reduce Cancer Chemotherapy Toxicity in Peer Reviewed Publication, according to Daily Body Restore, LLC

A probiotic with digestive enzymes supplement is effective at reversing chemotherapy- and antibiotic-induced damage to the gut microbiome.

July 25, 2018
·
3 min read
Genetown

Provident Healthcare Partners Advises Dermatology And Surgery Associates In Its Partnership With BelHealth Investment Partners

Dermatology and Surgery Associates has completed a recapitalization with BelHealth Investment Partners.

July 25, 2018
·
2 min read